UPLOAD Filing
Allarity Therapeutics, Inc.
Date: Feb. 19, 2026 · CIK: 0001860657 · Accession: 0000000000-26-001702
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-293420
Letter
February 19, 2026 Thomas Jensen Chief Executive Officer Allarity Therapeutics, Inc. 123 E Tarpon Ave Tarpon Springs, FL 34689 Re:Allarity Therapeutics, Inc. Registration Statement on Form S-3 Filed February 12, 2026 File No. 333-293420 Dear Thomas Jensen: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jessica Dickerson at 202-551-8013 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc:William N. Haddad, Esq.
Show Raw Text
February 19, 2026
Thomas Jensen
Chief Executive Officer
Allarity Therapeutics, Inc.
123 E Tarpon Ave
Tarpon Springs, FL 34689
Re:Allarity Therapeutics, Inc.
Registration Statement on Form S-3
Filed February 12, 2026
File No. 333-293420
Dear Thomas Jensen:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Jessica Dickerson at 202-551-8013 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:William N. Haddad, Esq.